Prayer #322: For the New COVID-19 Treatment Drug by Eli Lilly
The Food and Drug Administration (FDA) approved for emergency use for high-risk COVID-19 patients a drug combination of bamlamivimab and etesevimab. The drug combo can now be used with patients 12 and older, weighing at least 88 pounds, and with mild-to-moderate COVID-19 but with the risk of suffering a serious course of the virus. In a clinical trial involving 1,035 patients, the infusion of both of these drugs resulted in a reduction of hospitalizations and deaths of 70%. The drugs, which work by blocking the virus from binding to healthy cells, are most effective when administered soon after infection---within 10 days after the onset of symptoms. The drug combo was not approved for use with patients hospitalized with the virus or those in need of oxygen.
Pray that this newly-approved drug therapy for COVID-19 would prove to be very effective in preventing COVID hospitalizations and deaths. Pray that it could be widely distributed quickly.
Ps. 33:20: "Our soul waits for the LORD; He is our help and shield."